23 May 2013
Keywords: pharmagene, starts, ph, ii, trial, pgn0052, uk
Article | 22 December 2003
Pharmagene of the UK has initiated a Phase II proof-of-principle trialof its PGN0052, a synthetic version of human secretin, for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 December 2003
22 December 2003
22 May 2013
© 2013 thepharmaletter.com